ABVC BioPharma, Inc.
NasdaqCM:ABVC
Sector
Industries
Location
Market Cap
USD 51.11 M
Share Price
USD 3.01
Avg Daily Volume
352,561
Change (1 day)
-7.38%
Change (1 year)
Change (YTD)
336.23%
ABVC BioPharma, Inc. EBIT for the Trailing 12 Months (TTM) ending June 30, 2024: USD -8.07 M
ABVC BioPharma, Inc. EBIT is USD -8.07 M for the Trailing 12 Months (TTM) ending June 30, 2024, a -26.68% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.
-
ABVC BioPharma, Inc. EBIT for the Trailing 12 Months (TTM) ending June 30, 2023 was USD -11.01 M.
-
ABVC BioPharma, Inc. EBIT for the Trailing 12 Months (TTM) ending June 30, 2021 was USD -10.24 M, a 85.75% change year over year.
-
ABVC BioPharma, Inc. EBIT for the Trailing 12 Months (TTM) ending June 30, 2020 was USD -5.52 M.
StockViz
Competitors
AbbVie Inc.
USD 190.28
ABBV
-0.55
-0.29%
Novo Nordisk A/S
USD 70.93
NOVO-B.CO
+0.75
1.07%
Roche Holding AG
USD 345.06
RO.SW
-6.70
-1.91%
Novartis AG
USD 116.76
NOVN.SW
-0.57
-0.49%
AstraZeneca PLC
USD 145.14
AZN.L
-2.14
-1.46%
Abbott Laboratories
USD 126.54
ABT
+0.90
0.72%
Merck & Co., Inc.
USD 84.71
MRK
+0.60
0.71%
Thermo Fisher Scientific Inc.
USD 478.32
TMO
+3.29
0.69%
Amgen Inc.
USD 306.58
AMGN
-1.97
-0.64%
Boston Scientific Corporation
USD 106.14
BSX
-0.07
-0.07%
Pfizer Inc.
USD 24.79
PFE
-0.56
-2.21%
Gilead Sciences, Inc.
USD 116.20
GILD
+3.00
2.65%
Sanofi
USD 99.93
SAN.PA
-0.18
-0.18%
Vertex Pharmaceuticals Incorporated
USD 469.65
VRTX
-2.62
-0.56%
Bristol-Myers Squibb Company
USD 48.43
BMY
-0.51
-1.04%
Key Data
| Date | EBIT | EBITDA | Net Income | EPS (Diluted) |
|---|
Competitors
AbbVie Inc.
USD 190.28
ABBV
-0.55
-0.29%
Novo Nordisk A/S
USD 70.93
NOVO-B.CO
+0.75
1.07%
Roche Holding AG
USD 345.06
RO.SW
-6.70
-1.91%
Novartis AG
USD 116.76
NOVN.SW
-0.57
-0.49%
AstraZeneca PLC
USD 145.14
AZN.L
-2.14
-1.46%
Abbott Laboratories
USD 126.54
ABT
+0.90
0.72%
Merck & Co., Inc.
USD 84.71
MRK
+0.60
0.71%
Thermo Fisher Scientific Inc.
USD 478.32
TMO
+3.29
0.69%
Amgen Inc.
USD 306.58
AMGN
-1.97
-0.64%
Boston Scientific Corporation
USD 106.14
BSX
-0.07
-0.07%
Pfizer Inc.
USD 24.79
PFE
-0.56
-2.21%
Gilead Sciences, Inc.
USD 116.20
GILD
+3.00
2.65%
Sanofi
USD 99.93
SAN.PA
-0.18
-0.18%
Vertex Pharmaceuticals Incorporated
USD 469.65
VRTX
-2.62
-0.56%
Bristol-Myers Squibb Company
USD 48.43
BMY
-0.51
-1.04%